EP3659588A1 — Enterically coated cysteamine and salts thereof
Assigned to University of California · Expires 2020-06-03 · 6y expired
What this patent protects
Provided is a composition which comprises cysteamine or an acceptable salt thereof and an enteric coating. The cysteamine or acceptable salt thereof is encased by the enteric coating. The enterically coated cysteamine is granulated. The composition may be for use in treating cyst…
USPTO Abstract
Provided is a composition which comprises cysteamine or an acceptable salt thereof and an enteric coating. The cysteamine or acceptable salt thereof is encased by the enteric coating. The enterically coated cysteamine is granulated. The composition may be for use in treating cystinosis. Also provided is a process for manufacturing the composition.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.